Syncrosome recrute un Directeur d’Etudes précliniques – Metabolic disease.
DESCRIPTION DU POSTE : SYNCROSOME est une société de recherche préclinique, spécialisée dans la mise au point ...
13 mai, 2018 Syncrosome News
Arterial Hypertension
Pulmonary Arterial Hypertension
Myocardial Ischemia
Heart Failure
Blood loss
Parkinson’s Disease (PD)
Stroke
Brain Blood Barrier Passage
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Ulcer
Emesis & Nausea
Gastric Emptying
Intestinal Transit
Type 1 diabetes
Type 2 diabetes
Asthma
COPD
Cough
As an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds.
HIGH CONTENT EFFICACY DATA
PHYSIOLOGICAL BIOMARKERS
FUNCTIONAL EXPLORATION
CELLULAR, MOLECULAR AND INFLAMMATORY BIOMAKERS
IN VIVO EXPERIMENTS
RESOURCES CENTER
15
DISEASE MODELS
130
CUSTOMERS
40
TECHNICAL DATA SHEETS
Download Disease models, Technical sheets, …
Give a tour to Syncrosome Labs !
THEY TRUST US
LATEST NEWS
Neurodegenerative diseases and Neuro-inflammation – translation from rodent to patients?
Inflammation and microglial activation is a common component of the pathogenesis for several neurodegenerative diseases, including Alzheimer’s d...
25 avril, 2018 Central Nervous SystemSyncrosome keeps increasing its skills in the Cardiovascular area
In the framework of our development, we are proud to announce our political will to strengthen our capabilities for cardiovascular studies by the recr...
17 avril, 2018 Syncrosome NewsNew combination in a rat preclinical Congestive heart failure model shows promising results
Congestive heart failure (CHF), occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s ne...
10 avril, 2018 Cardiovascular